Clinical Trials
10 trialsNCT07548476 2026-05-04
ACE
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
NCT07501663 2026-04-14
Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study
Thomas Jefferson University
Phase NA Recruiting
NCT03183037 2024-05-03
Acupuncture for Symptoms of Nerve Damage
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02364726 2023-06-22
Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05673746 2023-01-06
Acu-CIPN
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Unknown
NCT05099562 2021-11-10
Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer
Affiliated Hospital of Qinghai University
Phase NA Unknown
NCT01541644 2019-11-07
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
University of Maryland, Baltimore
Phase NA Completed
NCT00891618 2016-10-31
Acupuncture for Chemo-Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02168894 2016-03-08
SINF: Peripheral Neuropathy in Cancer Survivors
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01892852 2013-07-17
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
Pusan National University Hospital
Phase NA Unknown